GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Livzon Pharmaceutical Group Inc (SZSE:000513) » Definitions » Long-Term Debt

Livzon Pharmaceutical Group (SZSE:000513) Long-Term Debt : ¥857 Mil (As of Mar. 2024)


View and export this data going back to 1993. Start your Free Trial

What is Livzon Pharmaceutical Group Long-Term Debt?

Livzon Pharmaceutical Group's Long-Term Debt for the quarter that ended in Mar. 2024 was ¥857 Mil.

Livzon Pharmaceutical Group's quarterly Long-Term Debt declined from Sep. 2023 (¥2,429 Mil) to Dec. 2023 (¥1,613 Mil) and declined from Dec. 2023 (¥1,613 Mil) to Mar. 2024 (¥857 Mil).

Livzon Pharmaceutical Group's annual Long-Term Debt increased from Dec. 2021 (¥637 Mil) to Dec. 2022 (¥1,974 Mil) but then declined from Dec. 2022 (¥1,974 Mil) to Dec. 2023 (¥1,613 Mil).


Livzon Pharmaceutical Group Long-Term Debt Historical Data

The historical data trend for Livzon Pharmaceutical Group's Long-Term Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Livzon Pharmaceutical Group Long-Term Debt Chart

Livzon Pharmaceutical Group Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Long-Term Debt
Get a 7-Day Free Trial Premium Member Only Premium Member Only - 360.32 636.78 1,974.44 1,612.77

Livzon Pharmaceutical Group Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Long-Term Debt Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 2,225.98 2,622.26 2,428.73 1,612.77 856.67

Livzon Pharmaceutical Group  (SZSE:000513) Long-Term Debt Explanation

Long-Term Debt is the sum of the carrying values as of the balance sheet date of all long-term debt, which is debt initially having maturities due after one year or beyond the operating cycle, if longer, but excluding the portions thereof scheduled to be repaid within one year or the normal operating cycle, if longer. Long-Term Debt includes notes payable, bonds payable, mortgage loans, convertible debt, subordinated debt and other types of long term debt.


Livzon Pharmaceutical Group Long-Term Debt Related Terms

Thank you for viewing the detailed overview of Livzon Pharmaceutical Group's Long-Term Debt provided by GuruFocus.com. Please click on the following links to see related term pages.


Livzon Pharmaceutical Group (SZSE:000513) Business Description

Traded in Other Exchanges
Address
38 Chuangye North Road, Headquarters Building, Jinwan District, Guangdong Province, Zhuhai, CHN, 519090
Livzon Pharmaceutical Group Inc is engaged in China's healthcare sector. As a pharmaceutical manufacturer, the company's portfolio comprises Western pharmaceutical preparations, bulk drugs, traditional Chinese medicines, as well as diagnostic reagents and equipment. Its drug address serious conditions such as gastrointestinal, cardiovascular, anti-infectious, antimicrobial, antineoplastic, hemopoietic system, and other conditions. It distributes its products within domestic markets and to overseas markets. It operates in a single reportable segment which is pharmaceutical manufacturing.

Livzon Pharmaceutical Group (SZSE:000513) Headlines

No Headlines